|
Brian Taylor served as EPI’s interim VP of Business Development. He quickly came up to speed on the technology relating to protein extraction from FFPE tissue and analysis of complex peptide mixtures by mass spectrometry, and represented the company well in discussions with customers, scientific collaborators and potential partners. He had an excellent grasp of trends in biomarker discovery and personalized medicine and worked with EPI’s management team to refine our corporate strategy. As VP of Business Development, Brian negotiated several important licensing, partnering, and biomarker discovery deals for EPI. He did an excellent job of resolving key issues and taking the deals to completion.
In his capacity as a Senior Partner at Biotech Venture Management (www.biotechvm.com), Brian Taylor provided part-time Director of Business Development services to KPL from December, 2004 to February 2006. During that time Brian was an integral part of KPL’s management team, working with Marketing to negotiate licensing deals for products and technology and interfacing effectively with Sales and Finance. He helped us clarify our product and company strategies and work through a number of long-standing issues. I heartily recommend him for your project or interim management position.
In 2004, Brian Taylor worked with us to identify a
global distribution partner for our cryopreserved neuronal
cell products. I was impressed by Brian’s ability
to quickly get a handle on the science of cryopreserved
neurons and see the market for our products. He used
his broad market knowledge and industry contacts to
identify several strong potential distribution partners
and represented QBM in subsequent contract negotiations.
QBM Cell Science benefited significantly from his strategic
insight, thorough preparation and strong negotiating
skills. I enjoyed working with Brian and wholeheartedly
recommend him for your consulting project.
Brian Taylor joined QIAGEN as a Product Manager in 1994,
directly from an academic teaching and research position.
He transitioned easily to commercial marketing, and rose
rapidly in our North American Marketing organization.
He and his marketing team successfully met our aggressive
growth goals and helped establish QIAGEN as a premier
biotech tools provider in North America.
In 2001, Brian became a Global Director of Strategic
Marketing, heading our Molecular Biology Research Group.
Brian and his group conducted a thorough re-evaluation
of our research products business, starting with individual
products and extending into entire markets. Brian’s
work helped us streamline our offerings, identify product
gaps, and focus our resources to be more competitive.
Brian impressed me with his market insight, broad understanding
of our business, and range of industry contacts. His
presentations were concise, well-constructed and notable
for their intellectual honesty. I know he will bring
the same quality to his services as a marketing and
strategy consultant.
I have worked with Brian since he joined QIAGEN in
1994. Over the last ten years, his marketing work with
our plasmid DNA purification, DNA cleanup, contract
DNA sequencing, PCR, genomic DNA, protein science, gene
silencing, cell biology and laboratory automation products
was exemplary. He was a molecular biologist before joining
QIAGEN, and his technical insight and understanding
of scientists’ needs came through in his work.
As a Director of Strategic Marketing, he was a member
of QIAGEN’s Technology Council. He was able to
quickly understand new technology and make solid recommendations
from both the marketing and technical viewpoints.
|
